Guidance for industry: Chronic cutaneous ulcer and burn wounds—developing products for treatment

Wound Repair and RegenerationVolume 9, Issue 4 p. 258-268 Guidance for industry: Chronic cutaneous ulcer and burn wounds—developing products for treatment DRAFT—NOT FOR IMPLEMENTATION FDA Wound Healing Clinical Focus Groupa, FDA Wound Healing Clinical Focus Groupa From the Food and Drug Administration's Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, and Center for Devices and Radiological Health.Search for more papers by this author FDA Wound Healing Clinical Focus Groupa, FDA Wound Healing Clinical Focus Groupa From the Food and Drug Administration's Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, and Center for Devices and Radiological Health.Search for more papers by this author First published: 04 March 2002 https://doi.org/10.1046/j.1524-475X.2001.00258.xCitations: 55 Reprint requests: No reprints will be available of this article. However it is accessible from the FDA web site, as noted in the preceding editorial. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume9, Issue4August 2001Pages 258-268 RelatedInformation